| AIVOX | OSMCX | AIVOX / OSMCX | |
| Total Expense Ratio | 1.71 | 2.13 | 80% |
| Annual Report Gross Expense Ratio | 1.76 | 2.13 | 83% |
| Fund Existence | 16 years | 28 years | - |
| Gain YTD | 25.803 | 15.981 | 161% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 505M | 2.73B | 19% |
| Annual Yield % from dividends | 0.00 | 0.48 | - |
| Returns for 1 year | 24.42 | 0.82 | 2,966% |
| Returns for 3 years | 36.37 | 2.40 | 1,514% |
| Returns for 5 years | -9.03 | -27.38 | 33% |
| Returns for 10 years | 30.49 | 7.46 | 409% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SVXFX | 74.21 | 0.58 | +0.79% |
| Smead International Value I1 | |||
| WSTYX | 83.25 | 0.14 | +0.17% |
| Macquarie Science and Technology Y | |||
| AWSSX | 18.36 | N/A | N/A |
| Invesco Global Core Equity R6 | |||
| CSMIX | 45.80 | -0.01 | -0.02% |
| Columbia Small Cap Value Discv A | |||
| CLTCX | 16.37 | -0.07 | -0.43% |
| Catalyst/Lyons Tactical Allocation C | |||